ChREBP Blocking Peptide Reference: 10006790-1 Peptide Sequence: murine amino acids 715-735 · To be used in conjunction with Cayman’s ChREBP polyclonal antibody (Catalog No. 10006789) to block protein-antibody complex formation during immunochemical analysis of ChREBP.
Sphingosine Kinase 1 Blocking Peptide Reference: 10006823-1 Peptide Sequence: human SPHK1 amino acids 264-274 (DLESEKYRRLG) · To be used in conjunction with Cayman’s Sphingosine Kinase 1 polyclonal antibody (Item No. 10006822) to block protein-antibody complex formation during immunochemical analysis of SPHK1 protein.
LPA1 Blocking Peptide Reference: 10006984-1 Peptide Sequence: human LPA1 amino acids 342-359 · To be used in conjunction with Cayman’s LPA1 polyclonal antibody (Catalog No. 10005280) to block protein-antibody complex formation during immunochemical analysis of LPA1.
CRTH2/DP2 Receptor (C-Term) Blocking Peptide Reference: 10007003-1 Peptide Sequence: CRTH2/DP2 protein amino acids 378-395 · To be used in conjunction with Cayman’s CRTH2/DP2 Receptor (C-Term) polyclonal antibody (Catalog No. 10007002) to block protein-antibody complex formation during immunochemical analysis of CRTH2
PTEN Blocking Peptide Reference: 10007073-1 Peptide Sequence: human PTEN amino acids 254-270 · To be used in conjunction with Cayman’s PTEN polyclonal antibody (Catalog No. 10005059) to block protein-antibody complex formation during immunochemical analysis of PTEN
PCSK9 (human) Blocking Peptide Reference: 10007186-1 Peptide Sequence: human PCSK9 amino acids (SRSGKRRGERMEA) · To be used in conjunction with Cayman’s PCSK9 (human) polyclonal antibody (Catalog No. 10007185) to block protein-antibody complex formation during immunochemical analysis of PCSK9.
PH Domain Leucine-rich Repeat Protein Phosphatase Blocking Peptide Reference: 10007192-1 Peptide Sequence: PH Domain Leucine-rich Repeat Protein Phosphatase (PHLPP) amino acids 1192-1205 (YQLDQLPDYYDTPL) · To be used in conjunction with Cayman’s PHLPP polyclonal antibody (Catalog No. 10007191) to block protein-antibody complex formation during immunochemical analysis of PHLPP
Lysophospholipase D Blocking Peptide Reference: 10007193-1 Peptide Sequence: rat lysoPLD amino acids 573-588 · To be used in conjunction with Cayman’s lysoPLD polyclonal antibody (Catalog No. 10005375) to block protein-antibody complex formation during immunochemical analysis of lysoPLD
GPR40 Blocking Peptide Reference: 10007206-1 Peptide Sequence: human GPR40 amino acids 210-222 · To be used in conjunction with Cayman’s GPR40 polyclonal antibody (Catalog No. 10007605) to block protein-antibody complex formation during immunochemical analysis of GPR40.
PEPCK Blocking Peptide Reference: 10007475-1 Peptide Sequence: PEPCK protein amino acids 5-17 · To be used in conjunction with Cayman’s PEPCK polyclonal antibody (Catalog No. 10004943) to block protein-antibody complex formation during immunochemical analysis of PEPCK
GPR35 Blocking Peptide Reference: 10007661-1 Peptide Sequence: human GPR35 · To be used in conjunction with Cayman’s GPR35 polyclonal antibody (Catalog No. 10007660) to block protein-antibody complex formation during immunochemical analysis of GPR35.
LDL Receptor Blocking Peptide Reference: 10007672-1 To be used in conjunction with Cayman’s NPC1L1 Polyclonal Antibody (Item No. 100076655) to block protein-antibody complex formation during immunochemical analysis of NPC1L1